JP2014513678A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014513678A5 JP2014513678A5 JP2014504051A JP2014504051A JP2014513678A5 JP 2014513678 A5 JP2014513678 A5 JP 2014513678A5 JP 2014504051 A JP2014504051 A JP 2014504051A JP 2014504051 A JP2014504051 A JP 2014504051A JP 2014513678 A5 JP2014513678 A5 JP 2014513678A5
- Authority
- JP
- Japan
- Prior art keywords
- veneered
- humanized
- chimeric
- human antibody
- isolated human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010078015 Complement C3b Proteins 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161473107P | 2011-04-07 | 2011-04-07 | |
| US61/473,107 | 2011-04-07 | ||
| PCT/US2012/032635 WO2012139069A2 (en) | 2011-04-07 | 2012-04-06 | Compositions and methods for treating diseases of protein aggregation involving ic3b deposition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014513678A JP2014513678A (ja) | 2014-06-05 |
| JP2014513678A5 true JP2014513678A5 (enExample) | 2015-06-11 |
Family
ID=46966276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014504051A Pending JP2014513678A (ja) | 2011-04-07 | 2012-04-06 | Ｉｃ３ｂ沈着を伴うタンパク質凝集に関する疾患を治療するための組成物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20120258041A1 (enExample) |
| EP (1) | EP2694109A4 (enExample) |
| JP (1) | JP2014513678A (enExample) |
| CA (1) | CA2832106A1 (enExample) |
| WO (1) | WO2012139069A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104010659A (zh) | 2011-12-19 | 2014-08-27 | 洛克菲勒大学 | 非唾液酸化的抗炎多肽 |
| US12384848B2 (en) | 2011-12-19 | 2025-08-12 | The Rockefeller University | Anti-inflammatory polypeptides |
| EP3092252B1 (en) | 2014-01-08 | 2019-09-18 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Antibody targeting cell surface deposited complement protein c3d and use thereof |
| EP3191509B1 (en) * | 2014-09-09 | 2019-02-20 | Euro-diagnostica AB | Antibodies specific for complement component c4d and uses thereof |
| EA202191471A1 (ru) | 2015-03-04 | 2022-01-31 | Зе Рокфеллер Юниверсити | Противовоспалительные полипептиды |
| WO2019089653A1 (en) * | 2017-10-30 | 2019-05-09 | Apellis Pharmaceuticals, Inc. | Treatment of disorders |
| JP2021519599A (ja) | 2018-04-03 | 2021-08-12 | サノフイＳａｎｏｆｉ | 抗原性ｏｓｐａポリペプチド |
| EP3773708A2 (en) | 2018-04-03 | 2021-02-17 | Sanofi | Antigenic epstein barr virus polypeptides |
| CN112512567A (zh) | 2018-04-03 | 2021-03-16 | 赛诺菲 | 抗原性呼吸道合胞病毒多肽 |
| JP2021519596A (ja) | 2018-04-03 | 2021-08-12 | サノフイＳａｎｏｆｉ | フェリチンタンパク質 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999012553A1 (en) * | 1997-09-08 | 1999-03-18 | Idec Pharmaceuticals Corporation | Methods for producing human antibodies in scid mice using dendritic cells |
| US8007798B2 (en) * | 1997-11-21 | 2011-08-30 | Genentech, Inc. | Treatment of complement-associated disorders |
| US20030235594A1 (en) * | 1999-09-14 | 2003-12-25 | Antigen Express, Inc. | Ii-Key/antigenic epitope hybrid peptide vaccines |
| DE60140457D1 (de) * | 2000-09-01 | 2009-12-24 | Blood Res Center | Veränderte, in gewünschter konformation stabilisierte polypeptide und verfahren zu deren herstellung |
| US6820011B2 (en) * | 2001-04-11 | 2004-11-16 | The Regents Of The University Of Colorado | Three-dimensional structure of complement receptor type 2 and uses thereof |
| US20090004183A1 (en) * | 2004-07-23 | 2009-01-01 | Taylor Ronald P | Compositions and Methods for Regulating the Alternative Pathway of Complement |
| WO2006083533A2 (en) * | 2005-01-14 | 2006-08-10 | The Regents Of The University Of California | Compositions and methods for inhibiting drusen formation and for diagnosing or treating drusen-related disorders |
| EP1945261A4 (en) * | 2005-11-07 | 2010-05-12 | Scripps Research Inst | COMPOSITIONS AND METHODS FOR CONTROLLING THE SPECIFICITY OF TISSUE FACTOR SIGNALING |
| MX2010006422A (es) * | 2007-12-11 | 2010-06-25 | Glaxo Group Ltd | Proteinas de union a antigenos. |
| US9291622B2 (en) * | 2009-05-21 | 2016-03-22 | Apellis Pharmaceuticals, Inc. | Complement assays and uses thereof |
-
2012
- 2012-04-06 EP EP12768510.5A patent/EP2694109A4/en not_active Withdrawn
- 2012-04-06 WO PCT/US2012/032635 patent/WO2012139069A2/en not_active Ceased
- 2012-04-06 US US13/441,818 patent/US20120258041A1/en not_active Abandoned
- 2012-04-06 US US14/110,137 patent/US20140186371A1/en not_active Abandoned
- 2012-04-06 JP JP2014504051A patent/JP2014513678A/ja active Pending
- 2012-04-06 CA CA2832106A patent/CA2832106A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014513678A5 (enExample) | ||
| EP4036119C0 (en) | ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN THE DIAGNOSIS OF CANCER | |
| JP2016502162A5 (enExample) | ||
| IL235607A0 (en) | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer | |
| HUE052134T2 (hu) | Antitestek, amelyek kötnek emberi programozott halál ligandum 1-hez (PD-L1) | |
| IL240335B (en) | Treatment of cancer using humanized anti-egfrviii chimeric antigen receptor | |
| LT3378535T (lt) | Humanizuoti antikūnai, atpažįstantys alfa-sinukleiną | |
| DK3191517T3 (da) | Krydsreaktive siglec-antistoffer | |
| JP2013525942A5 (enExample) | ||
| EP2935321A4 (en) | CHIMERIC ANTIGEN RECEPTORS | |
| DK2917360T3 (da) | Antistoffer mod S. aureus-overflade-determinanter | |
| LT3701971T (lt) | Junginiai, naudingi hibridinio imunoglobulino, turinčio nepeptidilo ryšį, gamyboje | |
| DK2580243T3 (da) | Antibodies against human cd38 | |
| EP2882295A4 (en) | ANTIMICROBIAL SOLID SURFACES AND TREATMENTS AND METHOD FOR THE PRODUCTION THEREOF | |
| JP2014518898A5 (enExample) | ||
| KR102355959B9 (ko) | 158p1d7 단백질에 결합하는 항체 약물 컨쥬게이트 | |
| DK2651436T3 (da) | Mycobakterie antigen sammensætning. | |
| JP2011170856A5 (enExample) | ||
| JP2013194055A5 (enExample) | ||
| JP2015501646A5 (enExample) | ||
| HRP20180928T1 (hr) | Protutijela za ligande bradikinin b1 receptora | |
| BR112014025299A8 (pt) | anticorpo de reação cruzada dirigido contra staphylococcus aureus, preparação farmacêutica e diagnóstica compreendendo o anticorpo, métodos de anticorpo de reação cruzada contra staphylococcus aureus | |
| IL244936A0 (en) | Cross-reactive staphylococcus aureus antibody sequences | |
| DK3154583T3 (da) | Humane monoklonale antistoffer mod gangliosid gd2 | |
| EP2695897A4 (en) | NEW ANTI-RECEPTOR ANTIBODY OF IL-23 HUMAN |